Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rassool

Showing results (141-150 of 222) with videos related to

Pageof 23
Sort By:
The Journal of Biological Chemistry|June 6, 2008
BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent mannerStella Maris Ranuncolo, Ling Wang, Jose M Polo, et al.
Molecular Cancer Research : MCR|April 2, 2015
c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated LeukemiasNidal Muvarak, Shannon Kelley, Carine Robert, et al.
Cancer Genetics and Cytogenetics|June 1, 1988
The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5' of the breakpoint cluster regionF Rassool, L Foroni, A Rahemtulla, et al.
BMJ Open|June 29, 2022
Technology to improve reliable access to oxygen in Western Uganda: study protocol for a phased implementation trial in neonatal and paediatric wardsSheillah Bagayana, Rami Subhi, Graham Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2026
Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancerEmmanuel B Asiedu, Ajay Kumar, Alexander Choi, et al.
Oncogene|February 2, 1999
Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemiaU R Peters, U Hasse, E Oppliger, et al.
Cancer Genetics and Cytogenetics|May 1, 1986
Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGLL Parreira, L Kearney, F Rassool, et al.
AIDS (London, England)|February 15, 2021
Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudineMark Nelson, Alan Winston, Andrew Hill, et al.
Journal of Leukocyte Biology|November 27, 2015
Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activationSean C Patro, Livio Azzoni, Jocelin Joseph, et al.
Genes, Chromosomes & Cancer|September 18, 1997
Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell linesS T Ong, K M Fong, S A Bader, et al.
Pageof 23

Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Biological Chemistry|June 6, 2008
BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent mannerStella Maris Ranuncolo, Ling Wang, Jose M Polo, et al.
Molecular Cancer Research : MCR|April 2, 2015
c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated LeukemiasNidal Muvarak, Shannon Kelley, Carine Robert, et al.
Cancer Genetics and Cytogenetics|June 1, 1988
The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5' of the breakpoint cluster regionF Rassool, L Foroni, A Rahemtulla, et al.
BMJ Open|June 29, 2022
Technology to improve reliable access to oxygen in Western Uganda: study protocol for a phased implementation trial in neonatal and paediatric wardsSheillah Bagayana, Rami Subhi, Graham Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2026
Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancerEmmanuel B Asiedu, Ajay Kumar, Alexander Choi, et al.
Oncogene|February 2, 1999
Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemiaU R Peters, U Hasse, E Oppliger, et al.
Cancer Genetics and Cytogenetics|May 1, 1986
Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGLL Parreira, L Kearney, F Rassool, et al.
AIDS (London, England)|February 15, 2021
Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudineMark Nelson, Alan Winston, Andrew Hill, et al.
Journal of Leukocyte Biology|November 27, 2015
Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activationSean C Patro, Livio Azzoni, Jocelin Joseph, et al.
Genes, Chromosomes & Cancer|September 18, 1997
Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell linesS T Ong, K M Fong, S A Bader, et al.
Pageof 23